NCT03075072 Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial Status ACTIVE_NOT_RECRUITING Phase NA
NCT03002532 Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer Status UNKNOWN Phase NA
NCT02974803 Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases Status TERMINATED Phase PHASE2
NCT02972333 Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M Status UNKNOWN Phase PHASE3
NCT02886585 Pembrolizumab In Central Nervous System Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02820454 Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles Status COMPLETED Phase PHASE1
NCT02747303 Frameless Stereotactic Radiosurgery for Intact Brain Metastases Status RECRUITING Phase PHASE2
NCT02735798 64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets Status WITHDRAWN Phase EARLY_PHASE1
NCT02732769 Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask. Status COMPLETED Phase NA
NCT02726568 High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases Status UNKNOWN Phase PHASE2
NCT02654106 Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases Status COMPLETED Phase PHASE2
NCT02636634 Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain Metastases Status COMPLETED Phase PHASE3
NCT02616393 Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases Status COMPLETED Phase PHASE2
NCT02605746 Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis Status COMPLETED Phase EARLY_PHASE1
NCT02581839 Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate Status COMPLETED Phase PHASE2
NCT02576522 Tumor Bed Hypofractionated IMRT After Surgery for Patients With Single,Large Brain Metastases From Solid Tumor Status COMPLETED Phase NA